GATC Health's AI Capabilities Integrated into Bioneex

SAN FRANCISCO and IRVINE, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bioneex.com, the world’s leading AI-powered marketplace platform for novel therapeutic assets, and GATC Health Corp, a leader in AI-driven drug discovery and risk analytics, are pleased to announce the integration of GATC Health’s predictive analysis capabilities into the Bioneex platform. This integration delivers advanced AI-driven predictions of drug candidate performance, providing greater confidence in asset validation for the global biotech and investment community.

“This collaboration elevates Bioneex’s AI-powered marketplace platform by providing our users with the most advanced, validated drug candidate analytics available. GATC’s data-driven predictive assessment empowers drug development companies, as well as strategic biopharma partners and venture capital investors, to make smarter, data-driven decisions,” said Bioneex Founder and CEO Dr. Smbat Rafayelyan.

Read the release here.